4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives $26.71 Consensus Target Price from Brokerages

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) has been given an average recommendation of “Moderate Buy” by the ten ratings firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock w…

Read Full Article →